-
oocyte release.
GnRH
agonists routinely used for this
purpose are: buserelin, leuprorelin, nafarelin, and triptorelin. In addition,
GnRHa medications may...
-
Eugster EA (September 2009). "Experience with the once-yearly
histrelin (
GnRHa)
subcutaneous implant in the
treatment of
central precocious puberty". Drug...
-
Eugster EA (September 2009). "Experience with the once-yearly
histrelin (
GnRHa)
subcutaneous implant in the
treatment of
central precocious puberty". Drug...
-
effect of
continued exposure to gonadotropin-releasing
hormone agonists (
GnRHa).
Conjoint Annual Meetings of the
American Fertility Society and the Canadian...
- and that 50
microg is
equivalent to 100
microg in
terms of IVF results.
GnRHa doses used in IVF are
derived from
treatment schedules used in disseminated...
- (
GnRHA), thus
decreasing the need for
monitoring by
preventing premature ovulation, and more
recently gonadotrophin-releasing
hormone antagonists (
GnRH...
- Tavistock, the
defendant (a
specialist National Health Service clinic)
offered GnRHa drug
treatment to under-18 patients. The complainant, who
sought this treatment...
- dysphoria,
which may
include gonadotrophin releasing hormone analogues (
GnRHa) to
suppress puberty;
oestrogen or
testosterone to
promote secondary ****...
- name for
puberty blockers is
gonadotropin releasing hormone analogues (
GnRHa).
Treatment of
transgender adolescents with
puberty blockers is
fairly recent...
-
continuous administration of a
gonadotropin releasing hormone agonist (
GnRHa). For egg donation,
there is
evidence of a
lower pregnancy rate and a higher...
